For the Inventor, By the Inventor

Enter inventor name

Tel Aviv, Israel

Lior Izhar

This inventor holds 17 USPTO granted patents and 33 published patent applications. Top assignee: Emendobio Inc.. Active years: 2022-2026.

USPTO Granted Patents = 17 (Patent Applications = 33)

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

Years Active: 2022-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698513 - CRISPR compositions and methods for promoting gene editing of ribosomal protein S19 (RPS19) gene (2026-08-04),

2. 12612625 - Compositions for genome editing (2026-04-28),

3. 12529043 - OMNI-103 CRISPR NUCLEASE (2026-01-20),

4. 12480140 - DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS ELANE GENE (2025-11-25),

5. 12454705 - Differential knockout of an allele of a heterozygous apolipoprotein A1 (APO1A) gene (2025-10-28),

6. 12435334 - Differential knockout of an allele of a heterozygous ELANE gene-II (2025-10-07),

7. 12359196 - Differential knockout of an allele of a heterozygous fibrinogen alpha chain (FGA) gene (2025-07-15),

8. 12274758 - Guide RNA that targets a mutant human inosine monophosphate deyhydrogenase I allele (2025-04-14),

9. 12258599 - Method to inactivate a mutant allele of angene (2025-03-25),

10. 12168062 - Guide RNA that targets a mutant human guanylate cyclase 2A allele (2024-12-17),

11. 12091688 - OMNI-103 CRISPR nuclease (2024-09-17),

12. 12031149 - Compositions and methods for promoting gene editing of CXCR4 gene (2024-07-09),

13. 11946077 - OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleases (2024-04-02),

14. 11827879 - Differential knockout of an allele of a heterozygous bestrophin 1 gene (2023-11-28),

15. 11795453 - Compositions for genome editing (2023-10-24),

Title: Lior Izhar: Innovator in Genetic Research

Introduction

Lior Izhar is a prominent inventor based in Tel Aviv, Israel, known for his significant contributions to genetic research. With a total of 13 patents to his name, he has made remarkable strides in the field of molecular genetics.

Latest Patents

Among his latest patents is the "Differential knockout of an allele of a heterozygous apolipoprotein A1 (APO1A) gene," which involves RNA molecules comprising a guide sequence portion with 17-20 nucleotides. This innovation has potential applications in various genetic therapies. Another notable patent is the "Differential knockout of an allele of a heterozygous ELANE gene-II," which outlines methods for inactivating a mutant allele of the elastase gene associated with severe congenital neutropenia and cyclic neutropenia. These patents reflect his commitment to advancing genetic research and therapeutic methods.

Career Highlights

Lior Izhar has established himself as a key figure in his field through his innovative research and patent contributions. His work has garnered attention for its potential impact on genetic disorders and therapies.

Collaborations

He collaborates with notable colleagues, including David Baram and Rafi Emmanuel, who contribute to his research endeavors and innovations.

Conclusion

Lior Izhar's work in genetic research exemplifies the intersection of innovation and science. His patents not only highlight his expertise but also pave the way for future advancements in genetic therapies.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

Loading…